Kai Sonntag

About Kai

We are biomedical scientists and have developed a technology to determine disease-specific pathways and molecules in human brain cells related to schizophrenia and Parkinson's disease. Our studies have identified molecules with therapeutic potential for neurodegenerative and psychiatric disorders. We are looking for a partner with expertise in business development and marketing to develop novel diagnostic and therapeutic strategies and products based on our findings.